Apogee Therapeutics has started its first clinical trial for APG990, a new treatment for atopic dermatitis, enrolling about 40 healthy volunteers, with interim results expected in 2025.
AI Assistant
APOGEE THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.